Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Operating Expenses: 2022-2023

Historic Operating Expenses for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $15.0 million.

  • Lexeo Therapeutics' Operating Expenses fell 1.47% to $15.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $68.5 million, marking a year-over-year change of. This contributed to the annual value of $105.8 million for FY2024, which is 54.37% up from last year.
  • According to the latest figures from Q4 2023, Lexeo Therapeutics' Operating Expenses is $15.0 million, which was down 26.14% from $20.3 million recorded in Q3 2023.
  • Over the past 5 years, Lexeo Therapeutics' Operating Expenses peaked at $20.3 million during Q3 2023, and registered a low of $14.0 million during Q2 2023.
  • For the 2-year period, Lexeo Therapeutics' Operating Expenses averaged around $17.0 million, with its median value being $16.6 million (2022).
  • The largest annual percentage gain for Lexeo Therapeutics' Operating Expenses in the last 5 years was 12.55% (2023), contrasted with its biggest fall of 1.47% (2023).
  • Over the past 2 years, Lexeo Therapeutics' Operating Expenses (Quarterly) stood at $15.2 million in 2022, then decreased by 1.47% to $15.0 million in 2023.
  • Its last three reported values are $15.0 million in Q4 2023, $20.3 million for Q3 2023, and $14.0 million during Q2 2023.